Format

Send to

Choose Destination
Clin Breast Cancer. 2003 Aug;4(3):212-7.

Phase I/II study of treatment of stage IV breast cancer with OKT3 x trastuzumab-armed activated T cells.

Author information

1
Immunotherapy and Blood and Stem Cell Transplantation Programs, Adele R. Decof Cancer Center, Roger Williams Medical Center, Providence, RI 02908, USA. llum@rwmc.org
PMID:
14499016
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center